I just started offering intracept. I see my first patients back in July. I did one commerical and one medicare patient. I'm sure I will get faster, but it definitely took a while. After considering the mortage, staff, insurance, etc costs, we figure that the ASC makes $2,000 in profit on a medicare case, which is worse than me doing 5 ESI/MBB in a hour (I flip rooms). And $595 is not enough of a pro fee to me for an hours work in the ASC, as after overhead I only get $300. I can make more per hour seeing clinic patients, and intracept patients require much more handholding and staff hours than ESI/RFA patients, so I expect I'm actually making less than $300/hr on medicare intracept patients.
I plan to only offer intracept to patients with commercial insurance going forward unless Relievant significantly lowers their pricing. I welcome other companies entering the market this fall as competition should bring lower costs all around.
I will still send out the ideal intracept medicare candidates to HOPD docs, but I'm not going to bother discussing with patient or organizing a referral for moderate candidates.
One thing about most SCS companies, is that they will adjust their kit pricing for medicare vs commerical payors. Relievant needs to also do this.
It’s only far that we all profit together. It's not fair to ask physicians to do medicare intracept for pennies while relievant makes the same $$$ either way.
Doing a ton of medicare intracept isn't in the cards for my practice until Relievant becomes more reasonable with their medicare kit pricing. And still I would only do this for medicare patients because I'm one of the owners of the practice receiving ASC revenue. On pro fees alone I would never do a medicare intracept case in a facility.